Landscapes / Companies
Hangzhou Highlightll Pharmaceutical Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
7 active
14 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Dec 2026Phase 3 trial completes | |||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Chronic Spontaneous Urticaria (CSU), Chronic Spontaneous Urticaria and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jun 2027Phase 1/2 trial completes | |||
| Next date | 30 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Atopic Dermatitis | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021